SUMMARY
Blood samples from critically ill patients are routinely collected via arterial catheters. The volume of blood discarded ("blank") as part of this method of sampling to obtain a specimen uncontaminated by electrolyte flush solution has been reported to range from 18% 1 to 30% 2 of the total blood volume drawn. For at least 30 years, there has been discussion in the medical literature concerning the relative importance of an iatrogenic contribution to the anaemia seen in hospitalized patients 3 . A study of blood transfusion in 142 ICU patients whose length of stay was greater than seven days concluded that phlebotomy was a major factor contributing to the need for RBC transfusions 4 . However, a recent prospective study of medical patients staying more than three days in ICU reported that diagnostic blood loss contributed a median of only 17% to the total estimated patient blood loss during the ICU stay 5 . Recent scientific editorials have urged intensivists to pay close attention to blood conservation during diagnostic studies 6, 7 . Despite these seemingly sensible recommendations, there is little evidence that reducing diagnostic blood loss in fact exerts a significant effect on levels of anaemia or transfusion requirements in ICU patients. In this context, the current study was undertaken to evaluate the performance of a blood conservation device used to return the "blank" blood from arterial lines during diagnostic testing.
MATERIALS AND METHODS
This randomized unblinded controlled trial was undertaken in a university-associated 14 bed adult medical and surgical ICU (excluding routine cardiothoracic surgical cases) over a four-month period ending August 2000. Consecutive adult patients were recruited who had an arterial line in situ on admission or who required an arterial line during their stay. The only exclusion criterion was an age less than 18 years.
We used the Venous Arterial Blood Management Protection Plus (VAMP Plus system), a commercial product of Baxter Healthcare (Toongabbie, N.S.W., Australia). This device is a variant of the original VAMP that was updated to incorporate a syringe instead of a reservoir/plunger to withdraw and reinfuse the "blank" blood volume (Figure 1 ). Eligible patients were randomized by ICU nursing staff using sequential sealed envelopes to receive a conventional arterial pressure monitoring system either with the blood conservation device (VAMP) or without (Control). The randomization schedule was generated electronically 8 in blocks of ten, using a standard routine 9 . There was no attempt to mask the treatment group as this was not practical. Patients remained in their own study group for the duration of their ICU stay regardless of the number of arterial lines that were required on clinical grounds. The trial period concluded when patients were discharged from ICU. Demographic and routine clinical data were collected including age, gender, APACHE II score on ICU entry 10 and duration of ICU stay. The bedside nurse recorded the nature and frequency of all diagnostic tests and the volume of all blood drawn and discarded (if any) from the arterial line. Approximately 5 ml of blood/flush solution was discarded from the arterial line of control patients prior to the collection of blood samples. The accuracy of collection of all clinical data was confirmed daily by one of the researchers (CM, CB or KB).
The primary outcome of this study was the change in Hb during the patient's ICU stay, calculated by subtracting the last available laboratory measured Hb prior to ICU discharge (discharge Hb) from the first laboratory Hb following transfer to ICU (admission Hb). Using a standard deviation for change in Hb during ICU admission of 23.4 g/l (estimated by a pilot study of 50 patients in the same ICU) it was calculated that in order to detect a difference in Hb of 10 g/l with a of 0.05 and 80% power, 80 subjects were required in each of two groups.
Our data was analysed on an intention to treat basis. Discontinuous or non-normally distributed variables were analysed with non-parametric tests (Mann-Whitney) while differences between proportions were examined by Chi-square or Fisher exact test as appropriate. A P value of 0.05 was considered statistically significant. Our institutional Clinical Research and Ethics Committee approved this study and waived the need for informed consent.
RESULTS
During the four-month trial period, 257 ICU patients were admitted of whom 213 had an arterial line for at least some of their stay. Of those patients 160 were randomized. The remaining 53 eligible patients with arterial lines were unable to be randomized, due to clerical errors in 35 cases and a temporary interruption to the supply of VAMP Plus system product in a further 18 cases.
Following successful randomization to the VAMP group, 8 of 80 patients (10%) received in violation of the trial protocol a control arterial pressure monitoring system for at least some of their ICU stay. In addition one patient aged 17 years was inadvertently randomized to VAMP and this patient was included in all analyses. Both groups were well matched for baseline characteristics including Hb at ICU admission (Table 1) .
There was a similar median length of stay (LOS) in ICU, requirement for renal replacement therapy, number and duration of use of arterial catheters between the two groups ( Table 1 ). The decrease in Hb, unadjusted for transfusion, during ICU admission between the VAMP and control patients was similar despite incorporation of the VAMP Plus system being associated with a significant reduction in the volume of "blank" blood discarded (Table 1) .
Fewer patients in the VAMP group received a transfusion of blood. Those transfused were well matched at baseline and had a similar ICU LOS. Transfused VAMP patients did not differ from control patients in the amount of packed cells received ( Table 1) .
The median change in Hb during ICU admission was marginally positive in those transfused and marginally negative in those not transfused. Compared to control patients, the VAMP device saved a median of approximately 20 ml of blood per ICU day (Table 1) .
No device malfunction or other adverse event attributable to the VAMP Plus system was detected during the trial.
DISCUSSION
Minimization of iatrogenic complications in critically ill patients is an important quality of care issue and the use of sterile reservoirs in arterial pressure monitoring devices has been strongly advocated to help conserve blood during diagnostic sampling 6, 7, 11, 12 . In our clinical evaluation, the VAMP Plus system performed satisfactorily as designed and reduced the amount of blood discarded during collection of diagnostic samples. The magnitude of the blood loss saving was small, at approximately 20 ml per ICU day, but similar to volumes reported by other authors evaluating alternative blood conservation devices 11, 13 . Also the overall volumes drawn from our patients were comparable to those found by a recent large multicentre European study 14 . Despite these advantages, our trial demonstrated that the incorporation of an arterial line reservoir did not influence significantly the Hb decrease that commonly accompanies critical illness.
While we found fewer patients in the VAMP group received a blood transfusion, the criteria for blood administration were not at all controlled in this study. As only a relatively small blood volume was saved in ICU (approximately 20 ml/day) it is almost certain that the transfusion differences we observed were due to factors other than the VAMP device. Small increases in Hb occurred in a minority of nontransfused patients. Our study did not control for fluid resuscitation volumes or any other therapy during the patient's ICU care. As anaemic patients did not routinely receive erythropoietic agents, it is most likely that fluctuations in hydration together with expected random variations in laboratory measurements explained the observed short term increases in Hb without transfusion.
In an evaluation of a different blood conservation device, Peruzzi and colleagues also found no significant change in Hb between their control and blood conservation groups 13 . An important explanation for the limited success of arterial blood conservation devices may come from the work of Von Ahsen and colleagues, who calculated diagnostic blood loss accounted for only a small proportion of the total blood loss that occurs in critical illness 5 . Thus the lack of impact of the VAMP Plus system on Hb in our study is not surprising given the relatively small blood saving per ICU day and the relatively short median duration of ICU admission for our patients. As the aetiology of anaemia in critical illness is multifactorial 5, 14 , modification of a single contributing factor, such as iatrogenic blood loss, is unlikely to reduce significantly the magnitude of the problem. Thus a device that can at best halve the volume withdrawn for diagnostic testing by avoiding the unnecessary discard of "blank" blood would be expected to have limited success in the prevention of critical care anaemia. "Blank" blood drawn and discarded in the control patients is to varying degrees diluted by flush solution and therefore the amount of Hb lost without the use of VAMP in these patients will be less that the amount implied by the discarded volume.
This study was unblinded as it was impractical to conceal the presence of the arterial device at the bedside. However, ICU staff separate from the trial investigators ordered the timing and volume of blood collected for diagnostic testing. This trial did not quantify possible adverse side-effects of the VAMP Plus system such as increased rates of bacteraemia. However, a previous study found no evidence of increased rates of infection associated with a blood conservation device 15 .
CONCLUSION
While the VAMP Plus system may confer advantages in selected critically ill patients, especially when a prolonged ICU admission or frequent blood sampling are anticipated, we conclude that the routine incorporation of such devices in general ICU practice cannot be supported on the basis of reduced levels of anaemia.
